Patents by Inventor Linxia XIAO

Linxia XIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
    Patent number: 10494373
    Abstract: Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: December 3, 2019
    Assignee: Guangdong Zhongsheng Pharmaceutical Co., Ltd
    Inventors: Charles Z. Ding, Shuhui Chen, Baoping Zhao, Xile Liu, Linxia Xiao, Chao Ding, Fei Wang, Jian Li
  • FUSED-RING OR TRICYCLIC ARYL PYRIMIDINE COMPOUND USED AS KINASE INHIBITOR
    Publication number: 20180354953
    Abstract: Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 20, 2016
    Publication date: December 13, 2018
    Inventors: Charles Z. DING, Shuhui CHEN, Baoping ZHAO, Xile LIU, Linxia XIAO, Chao DING, Fei WANG, Jian LI
  • Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
    Patent number: 10093656
    Abstract: Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: October 9, 2018
    Assignee: NANJING SANHOME PHARMACEUTICAL CO., LTD
    Inventors: Charles Z. Ding, Shuhui Chen, Baoping Zhao, Xile Liu, Linxia Xiao, Chao Ding, Fei Wang, Jian Li
  • Fused-Ring Or Tricyclic Aryl Pyrimidine Compound Used As Kinase Inhibitor
    Publication number: 20180072704
    Abstract: Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 14, 2017
    Publication date: March 15, 2018
    Inventors: Charles Z. DING, Shuhui CHEN, Baoping ZHAO, Xile LIU, Linxia XIAO, Chao DING, Fei WANG, Jian LI